Virax Biolabs Group Ltd. Class A had a revenue of 1.61K in the quarter ending Sep 30, 2025, with 16.69%. This bring the company's revenue in the last twelve months to 2.99K, Increased -52.84%. In the fiscal year ending Mar 31, 2025, Virax Biolabs Group Ltd. Class A had annual revenue of 6.33K with -95.95% growth.